{"transactions":[{"id":1323467,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2024-12-23T21:11:24.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":250100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":250100,"derivative":{"exercise_price":7.39,"exercise_date":"2025-12-19","expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":250100},"source":{"system":"sec-edgar","filing":"0001127602-24-029965","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224029965/form4.xml","form_type":"4"}},{"id":1323466,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-23T21:11:24.000Z","date":"2024-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2461,"price":7.39,"value":18186.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person."}],"balance_after":377867,"source":{"system":"sec-edgar","filing":"0001127602-24-029965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224029965/form4.xml","form_type":"4"}},{"id":1323465,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-23T21:11:24.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":120700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":380328,"source":{"system":"sec-edgar","filing":"0001127602-24-029965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224029965/form4.xml","form_type":"4"}},{"id":1329827,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T21:06:17.000Z","date":"2024-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7890,"price":7.53,"value":59411.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person."}],"balance_after":259628,"source":{"system":"sec-edgar","filing":"0001127602-24-029573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224029573/form4.xml","form_type":"4"}},{"id":1516577,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-15T11:19:34.000Z","date":"2024-05-14","kind":"purchase","planned":false,"acquired":true,"shares":36300,"price":5.57,"value":202191.0,"ownership":{"direct":true},"balance_after":266744,"source":{"system":"sec-edgar","filing":"0001127602-24-015373","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224015373/form4.xml","form_type":"4"}},{"id":1703750,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-20T21:35:45.000Z","date":"2023-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2482,"price":6.05,"value":15016.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person."}],"balance_after":227444,"source":{"system":"sec-edgar","filing":"0001127602-23-030181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223030181/form4.xml","form_type":"4"}},{"id":1708111,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2023-12-18T21:37:31.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":158500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":158500,"derivative":{"exercise_price":6.43,"exercise_date":"2024-12-14","expiration_date":"2033-12-14","underlying":"Common Stock","underlying_shares":158500},"source":{"system":"sec-edgar","filing":"0001127602-23-029831","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223029831/form4.xml","form_type":"4"}},{"id":1708110,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-18T21:37:31.000Z","date":"2023-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":5475,"price":6.43,"value":35204.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person."}],"balance_after":229926,"source":{"system":"sec-edgar","filing":"0001127602-23-029831","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223029831/form4.xml","form_type":"4"}},{"id":1708109,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-18T21:37:31.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":235401,"source":{"system":"sec-edgar","filing":"0001127602-23-029831","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223029831/form4.xml","form_type":"4"}},{"id":2079139,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2022-12-21T21:32:03.000Z","date":"2022-12-19","kind":"grant","acquired":true,"shares":158500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":158500,"derivative":{"exercise_price":10.63,"exercise_date":"2023-12-19","expiration_date":"2032-12-19","underlying":"Common Stock","underlying_shares":158500},"source":{"system":"sec-edgar","filing":"0001127602-22-028074","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222028074/form4.xml","form_type":"4"}},{"id":2079138,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-21T21:32:03.000Z","date":"2022-12-19","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":197966,"source":{"system":"sec-edgar","filing":"0001127602-22-028074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222028074/form4.xml","form_type":"4"}},{"id":2082612,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-19T21:55:39.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":5700,"price":10.9,"value":62130.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2022 to cover tax withholding obligations in connection with the vesting of 18,750 Restricted Stock Units. The sale occurred automatically to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.50 to $11.35. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":163966,"source":{"system":"sec-edgar","filing":"0001127602-22-027883","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222027883/form4.xml","form_type":"4"}},{"id":2436230,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-13T21:40:59.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error.  This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date."}],"balance_after":168719,"source":{"system":"sec-edgar","filing":"0001127602-22-001456","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222001456/form4a.xml","form_type":"4/A","original_submission_date":"2021-12-16"}},{"id":2470709,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2021-12-16T21:59:03.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":164000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":164000,"derivative":{"exercise_price":11.43,"exercise_date":"2022-12-14","expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":164000},"source":{"system":"sec-edgar","filing":"0001127602-21-031121","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221031121/form4.xml","form_type":"4"}},{"id":2470708,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-16T21:59:03.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":208719,"source":{"system":"sec-edgar","filing":"0001127602-21-031121","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221031121/form4.xml","form_type":"4"}},{"id":2496551,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-24T23:35:03.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":35258,"price":12.48,"value":440019.84,"ownership":{"direct":true},"balance_after":93719,"source":{"system":"sec-edgar","filing":"0001171843-21-008176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184321008176/ownership.xml","form_type":"4"}},{"id":2941055,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2020-12-17T21:23:00.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":332500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":332500,"derivative":{"exercise_price":8.31,"exercise_date":"2021-12-15","expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":332500},"source":{"system":"sec-edgar","filing":"0001127602-20-031782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220031782/form4.xml","form_type":"4"}},{"id":3060937,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-12T20:31:02.000Z","date":"2020-08-11","kind":"purchase","acquired":true,"shares":54000,"price":4.08,"value":220320.0,"ownership":{"direct":true},"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001127602-20-023449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220023449/form4.xml","form_type":"4"}},{"id":3164310,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":84847,"kind":"person","name":"Doyle Anthony","position":1,"cik":"0001808688","reported_name":"Doyle Anthony","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2020-05-04T20:08:12.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Initial Employee Option Grant, 200,000 of which become exercisable on the first anniversary of the grant date or upon termination if, within the first year of his employment, Mr. Doyle is impacted by a reduction in force at the Company, and the remainder of which will vest in three equal installments on the second, third and fourth anniversaries of the grant date."}],"balance_after":600000,"derivative":{"exercise_price":3.91,"exercise_date":"2021-04-30","expiration_date":"2020-04-30","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001127602-20-015179","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220015179/form4.xml","form_type":"4"}}]}